Urchinomics
PrivateLast Round
Strategic
Nov 12, 2025
Total Funding Raised
$5.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Urchinomics operates in Energy & Sustainability and is based in Halifax, Nova Scotia. Its latest recorded funding round was a Strategic round in November 2025.
Urchinomics is a restorative aquaculture company that turns ecologically destructive sea urchins into premium seafood products, helping to restore kelp forests.
Sector
Energy & Sustainability
Verticals
Circular Economy, ESG Analytics, Waste Management, Environmental Monitoring
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Urchinomics Comparables
Compare Urchinomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kita-Sanriku Factory INC. | 90% | |
| The Oyster Restoration Company | 63% | |
| Pine Island Redfish | 58% |
For institutional investors. Book with your work email.
Urchinomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 12, 2025 | ||||
| Strategic | Jul 24, 2024 | ||||
| Strategic | Jul 23, 2024 | ||||
| Strategic | Jan 19, 2023 | ||||
| Series A | Mar 30, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Urchinomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nippon Yusen Kabushiki Kaisha | Strategic |
| Builders Vision | Series A |
| Cadman Capital Group | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 79% MoM.
- Jun 20, 2026
Monthly visitors increased 55% MoM, reaching 3.3K.
For institutional investors. Book with your work email.
Urchinomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Urchinomics's valuation, stock price, and market status.
Is Urchinomics a public or private company?
Urchinomics is a private company.
What is the current stock price of Urchinomics?
Urchinomics is a private company, so its shares have no public market price. Caplight tracks Urchinomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Urchinomics worth (valuation)?
Valuation information for Urchinomics is not publicly available.
Can I buy Urchinomics stock?
Urchinomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Urchinomics's last funding round?
Urchinomics's most recent funding round was Strategic on November 12, 2025.
Who are the main investors in Urchinomics?
Key investors in Urchinomics include Cadman Capital Group.
Will Urchinomics IPO soon?
No public IPO plans have been announced for Urchinomics.
How can I track Urchinomics secondary market activity?
Caplight tracks bids, offers, and trades in Urchinomics's shares on secondary markets.